The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel…
By H. Bear, S. Anderson, Ann M. Brown, Roy E. Smith, E. Mamounas, B. Fisher, R. Margolese, Heather Theoret, A. Soran, D. Wickerham and 1 more. Journal of Clinical Oncology, 2003
1,132 citations recorded by the source corpus.
Subfields: Cancer Research, Pathology and Forensic Medicine, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/6878fbf208d1a1296c248b429eefdb4c7812f236
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
Citations in the corpus
- Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline (2021, background): “in peer-reviewed journals; (2) editorials, commentaries, letters, news articles, case reports, and narrative reviews; (3) published in a non-English language; (4) RCTs with , 100 patients total across treatment arms; (5) trials that evaluated only clinical response, biomarker end points, or breast-c”
- Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. (2008, background): “Preoperative therapy, initially used only for locally advanced breast cancer, has become more common for patients with operable disease.(1-17) This allows more individuals to undergo breast-conserving procedures and provides for observation of response to treatment.”
- Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. (2012, methodology): “Used by National Surgical Adjuvant Breast and Bowel Project.(5,13) ypT 1mic ypN0/ .”